Related Experiment Video
Updated: Feb 8, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
microRNA-30d mediated breast cancer invasion, migration, and EMT by targeting KLF11 and activating STAT3 pathway
Mingli Han1,2, Yimeng Wang3, Guangcheng Guo1
1Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Abstract:
miR-30d has been shown to play pivotal roles in cancer development, and has the potential to act as a diagnostic biomarker and therapeutic target in breast cancer. However, the specific function and molecular mechanism of miR-30d in breast cancer cell growth and metastasis is still unknown. The present study seeks to shed light on the potential contribution of the MiR-30d-KLF-11-STAT3 pathway in breast cancer. The results revealed that miR-30d levels were markedly increased in the breast cancer cell lines BT474, MDA-MB-231, HCC197, and MDA-MB-468 compared with the non-tumor mammary gland MCF10A cell line. Furthermore, the miR-30d mimic increased BT474 and MDA-MB-231 breast cancer cell survival, inhibited apoptosis and increased Bcl-2 expression, whilst inhibited Bax protein levels. miR-30d mimics promote BT474 and MDA-MB-231 cell migration, invasion, and mediate the EMT phenotype. However, miR-30d inhibitors reverse all of the effects of miR-30d mimics on breast cancer cell biology. Also, we observed that KLF-11 is a direct target of miR-30d and KLF-11 and pSTAT3 expression are determined by miR-30d. Finally, the results suggest that miR-30d plays essential roles in breast cancer cells in a manner that is dependent on the levels of KLF-1 and pSTAT3. In summary, miR-30d appears to be a novel diagnostic biomarker and treatment target in breast cancer.
Insights
MicroRNA-30d (miR-30d) promotes breast cancer growth and metastasis by regulating the KLF-11-STAT3 pathway. Inhibiting miR-30d reverses these effects, suggesting miR-30d as a potential biomarker and therapeutic target.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- MicroRNA-30d (miR-30d) is implicated in cancer development and shows potential as a breast cancer biomarker and therapeutic target.
- The precise role and molecular mechanisms of miR-30d in breast cancer progression, including cell growth and metastasis, remain largely undefined.
Purpose of the Study:
- To elucidate the role of the miR-30d-KLF-11-STAT3 pathway in breast cancer.
- To investigate the impact of miR-30d on breast cancer cell proliferation, apoptosis, migration, invasion, and epithelial-mesenchymal transition (EMT).
Main Methods:
- Quantitative analysis of miR-30d expression in breast cancer cell lines (BT474, MDA-MB-231, HCC197, MDA-MB-468) and a non-tumorigenic cell line (MCF10A).
- Assessment of cell survival, apoptosis (Bcl-2, Bax expression), migration, and invasion following miR-30d mimic or inhibitor treatment.
- Investigation of the direct targeting of KLF-11 by miR-30d and its effect on KLF-11 and pSTAT3 expression.
Main Results:
- miR-30d levels were significantly elevated in multiple breast cancer cell lines compared to MCF10A.
- miR-30d mimics enhanced cell survival, inhibited apoptosis, and promoted migration and invasion, mediating EMT.
- miR-30d directly targets KLF-11, influencing KLF-11 and pSTAT3 levels, with inhibitors reversing these effects.
Conclusions:
- miR-30d plays a critical role in breast cancer cell biology, dependent on KLF-11 and pSTAT3 levels.
- miR-30d functions as a potential diagnostic biomarker and therapeutic target for breast cancer.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs
Cancer Cell Migration through Invadopodia
Targeted Cancer Therapies
There are several types of targeted therapies against...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...

